Breaking News Headlines Today | Ground News

New Year’s Sale — Build a balanced news diet with 40% off Vantage

Pharmaceutical Commerce image

News from Pharmaceutical Commerce

Pharmaceutical Commerce’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

Is Pharmaceutical Commerce credible or reliable? Our Factuality score answers both of those questions. When it comes to Pharmaceutical Commerce, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about Pharmaceutical Commerce

Where is Pharmaceutical Commerce located?Pharmaceutical Commerce's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Pharmaceutical Commerce News

FDA Approves First Daily Pill for Weight Loss Treatment — REUTERS / pwu404

Business · United States

FDA Approves First Daily Pill for Weight Loss Treatment

63% Center coverage: 257 sources

The U.S. Food and Drug Administration on Monday approved the first oral medication to treat obesity — a pill version of the weight-loss drug Wegovy. The pill contains semaglutide, the same active ingredient as injectable Wegovy and Ozempic.See the Story

Samsung Biologics to buy US drug production facility from GSK for $280 million — REUTERS / ixx511

Samsung · South Korea

Samsung Biologics to buy US drug production facility from GSK for $280 million

65% Center coverage: 23 sources

South Korea's Samsung Biologics said on Monday it is acquiring its first U.S. drug production facility from GSK or $280 million to respond to long-term U.S. market demand.See the Story

GLP-1 Weight Loss Drugs Are Getting a Major Upgrade After New FDA Approval

Diabetes · United States

GLP-1 Weight Loss Drugs Are Getting a Major Upgrade After New FDA Approval

Coverage: 7 sources

Novo Nordisk's latest innovation is expected to be available next month.See the Story

Breaking News Topics Related to Pharmaceutical Commerce